Milestone Pharmaceuticals
Focus: Milestone Pharmaceuticals is a Montreal-based specialty pharmaceutical company focused on small-molecule therapeutics in neurology and cardiology, with a concentrated portfolio built around etripamil formulations.
Profile data last refreshed 3h ago · AI intelligence enriched 3w ago
Open Jobs
1
Should You Work at Milestone Pharmaceuticals?
AI assessmentMilestone offers a rare launch-stage opportunity with a long-runway product, but extreme opaqueness on company scale, finances, and hiring velocity makes risk assessment difficult for career planning.
Why Work Here
- CARDAMYST (etripamil) recently launched with a long exclusivity window (LOE: 2042), providing stable product revenue and career visibility into a mature commercial lifecycle.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Late-stage
6 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Launch15.7yr
L-type calcium channel inhibitor newly approved via NDA; first-in-class opportunity in acute PSVT management with 19-year exclusivity runway provides substantial career platform.
Help build intelligence for Milestone Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.